These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 450356)

  • 1. A maternal death associated with prostaglandin E2.
    Patterson SP; White JH; Reaves EM
    Obstet Gynecol; 1979 Jul; 54(1):123-4. PubMed ID: 450356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of extrauterine fetal death with failure of prostaglandin E2 suppositories.
    Orr JW; Huddleston JF; Goldenberg RL; Knox GE; Davis RO
    Obstet Gynecol; 1979 Mar; 53(3 Suppl):56S-58S. PubMed ID: 424129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences with prostaglandin E 2 and F 2 alpha in the termination of pregnancy and labor induction in intrauterine fetal death].
    Kunz J; Schreiner WE
    Schweiz Med Wochenschr; 1977 Jun; 107(22):757-63. PubMed ID: 877524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic abortions in the second trimestre of pregnancy with prostaglandine gel (author's transl)].
    Heinzl S
    Geburtshilfe Frauenheilkd; 1978 Mar; 38(3):220-6. PubMed ID: 640366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between vaginal prostaglandin E2 suppositories and intrauterine extra-amniotic prostaglandins in the management of fetal death in utero.
    Scher J; Jeng DY; Moshirpur J; Kerenyi TD
    Am J Obstet Gynecol; 1980 Aug; 137(7):769-72. PubMed ID: 7405968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous prostaglandin E2 and 16-phenoxy prostaglandin E2 methyl sulfonylamide for induction of fetal death in utero.
    Gruber WS; Baumgarten K
    Am J Obstet Gynecol; 1980 May; 137(1):8-14. PubMed ID: 7369292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
    Kent DR; Goldstein AI; Linzey EM
    J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal prostaglandin E2 for interruption of pregnancy and management of intrauterine death.
    Thiery M; Amy JJ; Decoster JM
    Z Geburtshilfe Perinatol; 1979 Jun; 183(3):218-22. PubMed ID: 483950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA; Hanson FW
    Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two prostaglandins used to terminate midtrimester pregnancy.
    Gookin KS; White CK; Whitworth NS; Wiser WL; Morrison JC
    South Med J; 1984 Jun; 77(6):717-8, 721. PubMed ID: 6587588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rupture of the cervix during prostaglandin termination of pregnancy.
    El-Etriby EK; Daw E
    Postgrad Med J; 1981 Apr; 57(666):265-6. PubMed ID: 7291112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic midtrimester abortion by the intra-uterine administration of prostaglandins. Experience of Groote Schuur Hospital, 1974-1975.
    Sher G
    S Afr Med J; 1976 Jul; 50(30):1173-7. PubMed ID: 823651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal prostaglandin E2 in the management of fetal intrauterine death.
    Southern EM; Gutknecht GD; Mohberg NR; Edelman DA
    Br J Obstet Gynaecol; 1978 Jun; 85(6):437-41. PubMed ID: 350261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac output response to prostaglandin E2-induced abortion in the second trimester.
    Willis DC; Caton D; Levelle JP; Banner T
    Am J Obstet Gynecol; 1987 Jan; 156(1):170-3. PubMed ID: 3467593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine rupture with the use of vaginal prostaglandin E2 suppositories.
    Sandler RZ; Knutzen VK; Milano CM; Gleicher N
    Am J Obstet Gynecol; 1979 Jun; 134(3):348-9. PubMed ID: 453268
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rupture of a healthy uterus in a prostaglandin-induced abortion in the second trimester].
    Larue L; Marpeau L; Percque M; Castiel J; Guettier X; Maghioracos P; Barrat J
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(2):269-72. PubMed ID: 2071873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories.
    Lauersen NH; Cederqvist LL; Wilson KH
    Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of oral prostaglandin E2 in the management of intrauterine fetal death.
    Kho FH; de Bruin AJ
    Prostaglandins; 1979 Oct; 18(4):663-72. PubMed ID: 531233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-trimester abortion by intramuscular 15-methyl-prostaglandin F2 alpha or intravaginal prostaglandin E2 suppositories: a randomized trial.
    Borgida AF; Rodis JF; Hanlon W; Craffey A; Ciarleglio L; Campbell WA
    Obstet Gynecol; 1995 May; 85(5 Pt 1):697-700. PubMed ID: 7724098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third-trimester uterine rupture associated with vaginal prostaglandin E2.
    Sawyer MM; Lipshitz J; Anderson GD; Dilts PV
    Am J Obstet Gynecol; 1981 Jul; 140(6):710-1. PubMed ID: 7258248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.